| Mrs Ethelyn Denise Lumpkin, | |
|
3205 Winterwood Ave, Albany, GA 31721-4527 | |
| (229) 869-9476 | |
| (229) 434-2665 |
| Full Name | Mrs Ethelyn Denise Lumpkin |
|---|---|
| Gender | Female |
| Speciality | Counselor - School |
| Location | 3205 Winterwood Ave, Albany, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851919336 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YS0200X | Counselor - School | 197614 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ethelyn Denise Lumpkin, 3205 Winterwood Ave, Albany, GA 31721-4527 Ph: (229) 869-7636 | Mrs Ethelyn Denise Lumpkin, 3205 Winterwood Ave, Albany, GA 31721-4527 Ph: (229) 869-9476 |
News Archive
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, and AXA Diagnostics, a privately owned company that markets specialized diagnostic tests, announced today the signing of an exclusive distribution agreement in Italy for Rosetta Genomics' three currently available diagnostic tests.
Many people with schizophrenia have marked problems with motivation, failing to initiate and persist in goal-directed behavior. These negative symptoms of schizophrenia can be disabling and prevent individuals from realizing their potential.
Chembio Diagnostics, Inc., a company that develops, manufactures, licenses, and markets proprietary rapid diagnostic tests, announced today that it will present at a meeting of the Blood Products Advisory Committee ("BPAC") of the U.S. Food and Drug Administration ("FDA") in Bethesda, Maryland, on the afternoon of November 17, 2009.
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
The U. S. Patent and Trademark Office recently issued a patent to the U. S. Department of Health and Human Services involving resiniferatoxin, or RTX, an experimental compound that represents a potential new class of drugs to alleviate the intractable pain that can occur in people with advanced cancer, severe arthritis, and other extremely chronic conditions.
› Verified 7 days ago
Susan Hardie, LPC Counselor Medicare: Medicare Enrolled Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-7001 Fax: 229-312-7006 | |
Cynthia Morrell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 506 N Jackson St, Albany, GA 31701 Phone: 229-889-7200 Fax: 229-889-7393 | |
Dena Payn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1211 Palmyra Rd, Albany, GA 31701 Phone: 229-439-8686 | |
Malcolm Rundell Bynum, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 321 William Jr St, Albany, GA 31707 Phone: 229-430-5100 | |
Mr. Roderick Mcleod Wilcox, LCSW, MFT Counselor Medicare: Accepting Medicare Assignments Practice Location: 1216 Whispering Pines Rd, Albany, GA 31707 Phone: 229-435-1729 Fax: 229-435-1720 | |
Mr. Kenneth George Myers Jr., M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1511 W 3rd Ave, Suite 104, Albany, GA 31707 Phone: 229-854-4886 | |
Kareema Williams, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 11th Ave, Albany, GA 31701 Phone: 229-430-4140 |